Vilazodone
|
|
Synonyms
|
EMD-515259
|
Brand names
|
Viibryd
|
IUPAC name
|
IUPAC name
|
5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxamide
|
|
ChemSpider
|
5293518
|
DrugBank
|
DB06684
|
PubChem
|
6918314
|
PDB fields
|
N/A
|
Formula
|
C26H27N5O2
|
InChI
|
InChI
|
1S/C26H27N5O2/c27-16-18-4-6-23-22(13-18)19(17-29-23)3-1-2-8-30-9-11-31(12-10-30)21-5-7-24-20(14-21)15-25(33-24)26(28)32/h4-7,13-15,17,29H,1-3,8-12H2,(H2,28,32)
|
|
InChIKey
|
InChIKey
|
SGEGOXDYSFKCPT-UHFFFAOYSA-N
|
|
SMILES
|
SMILES
|
NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
| (Jmol 3D structure)
|
Mol. mass
|
441.5249 g/mol
|
Vilazodone is a multi-modal antidepressant that is currently, solely marketed in the U.S.A., it was first FDA approved in 2011.
External links[]
ν · τ · εAntidepressants (ATC: N06A) |
---|
|
First-generation | | |
---|
| TCAs | Amitriptyline, amoxapine, butriptyline, clomipramine, desipramine, dosulepin, doxepin, imipramine, maprotiline, nortriptyline, protriptyline, trimipramine |
---|
|
---|
|
Second-generation | |
---|